FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164338743> ?p ?o ?g. }

• W3164338743 endingPage "105685" @default.
• W3164338743 startingPage "105685" @default.
• W3164338743 abstract "Erlotinib, an EGFR tyrosine kinase inhibitor has been introduced into cancer chemotherapy. However, the therapeutic effects of erlotinib in hepatocellular carcinoma (HCC) remain vaguely understood. Our previous study found that a hypoxia-mediated PLAGL2-EGFR-HIF-1/2α signaling loop in HCC decreased response to erlotinib. The current study has demonstrated that the combination of erlotinib and 2ME2 exerted synergistic antitumor effects against HCC. Further investigation showed that erlotinib increased the expression level of EGFR, HIF-2α, and PLAGL2, which contributes to the insensitivity of hypoxic HCC cells to erlotinib. The simultaneous exposure to 2ME2 effectively inhibited the expression level of EGFR, HIF-2α, and PLAGL2 that was induced by erlotinib. This contributes to the synergistic effect of the two therapeutic agents. Furthermore, the combination of erlotinib and 2ME2 induced apoptosis and inhibited the stemness of hypoxic HCC cells. Our findings potentially explain the mechanism of HCC insensitivity to erlotinib and provide a new strategy of combining EGFR and HIF1/2α inhibitors for HCC treatment." @default.
• W3164338743 created "2021-06-07" @default.
• W3164338743 creator A5004068069 @default.
• W3164338743 creator A5012447346 @default.
• W3164338743 creator A5013793832 @default.
• W3164338743 creator A5022664391 @default.
• W3164338743 creator A5028976572 @default.
• W3164338743 creator A5033032425 @default.
• W3164338743 creator A5053066397 @default.
• W3164338743 creator A5058329855 @default.
• W3164338743 creator A5060002817 @default.
• W3164338743 creator A5060729549 @default.
• W3164338743 creator A5073236619 @default.
• W3164338743 creator A5077706866 @default.
• W3164338743 creator A5080268249 @default.
• W3164338743 creator A5086428154 @default.
• W3164338743 creator A5087631945 @default.
• W3164338743 date "2021-07-01" @default.
• W3164338743 modified "2023-10-16" @default.
• W3164338743 title "2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop" @default.
• W3164338743 cites W1972802699 @default.
• W3164338743 cites W1995124125 @default.
• W3164338743 cites W1996106353 @default.
• W3164338743 cites W2004053427 @default.
• W3164338743 cites W2007337036 @default.
• W3164338743 cites W2010386340 @default.
• W3164338743 cites W2014245338 @default.
• W3164338743 cites W2020531037 @default.
• W3164338743 cites W2024968505 @default.
• W3164338743 cites W2029579528 @default.
• W3164338743 cites W2033400628 @default.
• W3164338743 cites W2038047082 @default.
• W3164338743 cites W2038625523 @default.
• W3164338743 cites W2062843221 @default.
• W3164338743 cites W2069698188 @default.
• W3164338743 cites W2085002868 @default.
• W3164338743 cites W2097607584 @default.
• W3164338743 cites W2113672655 @default.
• W3164338743 cites W2115497785 @default.
• W3164338743 cites W2158207366 @default.
• W3164338743 cites W2165707701 @default.
• W3164338743 cites W2166435019 @default.
• W3164338743 cites W2536907894 @default.
• W3164338743 cites W2805006390 @default.
• W3164338743 cites W2917837889 @default.
• W3164338743 doi "https://doi.org/10.1016/j.phrs.2021.105685" @default.
• W3164338743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34022398" @default.
• W3164338743 hasPublicationYear "2021" @default.
• W3164338743 type Work @default.
• W3164338743 sameAs 3164338743 @default.
• W3164338743 citedByCount "8" @default.
• W3164338743 countsByYear W31643387432021 @default.
• W3164338743 countsByYear W31643387432022 @default.
• W3164338743 countsByYear W31643387432023 @default.
• W3164338743 crossrefType "journal-article" @default.
• W3164338743 hasAuthorship W3164338743A5004068069 @default.
• W3164338743 hasAuthorship W3164338743A5012447346 @default.
• W3164338743 hasAuthorship W3164338743A5013793832 @default.
• W3164338743 hasAuthorship W3164338743A5022664391 @default.
• W3164338743 hasAuthorship W3164338743A5028976572 @default.
• W3164338743 hasAuthorship W3164338743A5033032425 @default.
• W3164338743 hasAuthorship W3164338743A5053066397 @default.
• W3164338743 hasAuthorship W3164338743A5058329855 @default.
• W3164338743 hasAuthorship W3164338743A5060002817 @default.
• W3164338743 hasAuthorship W3164338743A5060729549 @default.
• W3164338743 hasAuthorship W3164338743A5073236619 @default.
• W3164338743 hasAuthorship W3164338743A5077706866 @default.
• W3164338743 hasAuthorship W3164338743A5080268249 @default.
• W3164338743 hasAuthorship W3164338743A5086428154 @default.
• W3164338743 hasAuthorship W3164338743A5087631945 @default.
• W3164338743 hasConcept C121608353 @default.
• W3164338743 hasConcept C126322002 @default.
• W3164338743 hasConcept C178790620 @default.
• W3164338743 hasConcept C185592680 @default.
• W3164338743 hasConcept C2778019345 @default.
• W3164338743 hasConcept C2778087573 @default.
• W3164338743 hasConcept C2779438470 @default.
• W3164338743 hasConcept C2909325608 @default.
• W3164338743 hasConcept C502942594 @default.
• W3164338743 hasConcept C540031477 @default.
• W3164338743 hasConcept C71924100 @default.
• W3164338743 hasConcept C7836513 @default.
• W3164338743 hasConcept C98274493 @default.
• W3164338743 hasConceptScore W3164338743C121608353 @default.
• W3164338743 hasConceptScore W3164338743C126322002 @default.
• W3164338743 hasConceptScore W3164338743C178790620 @default.
• W3164338743 hasConceptScore W3164338743C185592680 @default.
• W3164338743 hasConceptScore W3164338743C2778019345 @default.
• W3164338743 hasConceptScore W3164338743C2778087573 @default.
• W3164338743 hasConceptScore W3164338743C2779438470 @default.
• W3164338743 hasConceptScore W3164338743C2909325608 @default.
• W3164338743 hasConceptScore W3164338743C502942594 @default.
• W3164338743 hasConceptScore W3164338743C540031477 @default.
• W3164338743 hasConceptScore W3164338743C71924100 @default.
• W3164338743 hasConceptScore W3164338743C7836513 @default.
• W3164338743 hasConceptScore W3164338743C98274493 @default.
• W3164338743 hasFunder F4320321001 @default.
• W3164338743 hasFunder F4320321540 @default.

• next